Abstract: Provided is a compound comprising a first ligand LA of where at least one of RA and RB is a structure of

Abstract: A compound having a formula M(LA)x(LB)y(LC)z, where ligand LA is ligand LB is and ligand LC is is disclosed. In formula M(LA)x(LB)y(LC)z, M is a metal having an atomic number greater than 40; x is 1 or 2; y and z are independently 0, 1, or 2; x+y+z is the oxidation state of the metal M; A1-A8 are carbon or nitrogen; ring B is bonded to ring A through a C—C bond; M is bonded to ring A through a M-C bond; X is O, S, Se, CRR?, or NR1; rings C and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; at least one R4 is a five-membered or six-membered heterocyclic ring which can be further substituted by RE; each R substituent is independently selected from the several substituents; and any adjacent R substitutents are optionally joined to form a ring.

Abstract: Novel ligands for metal complexes that are useful as phosphorescent emitters in OLEDs are disclosed. The ligands contain an aryl covalently bonded to the coordinating metal where the aryl group has at least two different alkyl side chains that are linked ortho and para compared to the linkage of the coordinating metal on that aryl group.

Abstract: Provided are compounds of Formula Ir(LA)x(LC)y, wherein: ligand LA has Formula I? and ligand LC has Formula II?

Abstract: A compound of Formula I having isoindoline moiety is disclosed. Their unique configuration of the fused rings enable the compound to exhibit phosphorescent emission in red color region to near infrared region and are useful as emitter materials in organic electroluminescence device.

Abstract: A compound comprising a first ligand LA of Formula I, where moiety A has a structure of Formula II, or Formula III, and G comprises a structure of Formula IV, is provided. In LA, moiety B is one or more rings; ring C is a 5- or 6-membered ring; each of Z1, Z2, Z3, and X1 to X8 is C or N; K is a direct bond or selected from the group consisting of O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); each R?, R?, RA, RB, RC, and RD is hydrogen or a General Substituent; LA is coordinated to a metal M selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Pd, Ag, Au, and Cu; and any two substituents may be joined or fused to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound of a first ligand LA of Formula I, is provided. In Formula I, moieties A and B are each a monocyclic ring or a polycyclic fused-ring system; Z1 to Z4 are each C or N; K is a direct bond, O, or S; each RA and RB is independently a hydrogen or a General Substituent; at least one RA or RB is R*, wherein R* has a structure of Formula II, —L—GeR1R2R3; L is a direct bond or an organic linker; and LA is coordinated to a metal M by the dashed lines; and metal M is selected from Ir, Rh, Re, Ru, Os, Pt, Pd, Ag, Au, or Cu.

Abstract: A compound comprising a first bidentate ligand LA having a structure of Formula I, is provided. In Formula I, each of Y1 to Y12 is CR or N; each R can be same or different; each R is hydrogen or a substituent; at least one pair selected from Y3-Y4, Y7-Y8, or Y11-Y12 are CR and the Rs are joined or fused into a ring; and LA is complexed to a metal M selected from the group consisting of Os, Ir, Pd, and Pt. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Tetradentate platinum complexes comprising an imidazole/benzimidazole carbene having a structure of Formula I is disclosed. In Formula I, M is Pd or Pt. These platinum carbenes with the specific substituents disclosed herein are novel and provides phosphorescent emissive compounds that exhibit physical properties that can be tuned, such as sublimation temperature, emission color, and device stability.

Abstract: A compound comprising a ligand LA coordinated to a metal M, the ligand LA selected from the group consisting of Formula I, Formula II, and Formula III ring A is a 5- or 6-membered carbocyclic or heterocyclic ring; wherein ring A of Formula I connects to ring B at X1, X2, or X3 to form a five-membered chelate ring with the metal; Z1 and Z2 are independently selected from C or N; and X1 to X10 are independently selected from C or N. An organic light emitting device (OLED) comprising an anode, a cathode and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound selected from Formula I, Formula II, or Formula III, and a consumer product comprising the OLED.

Abstract: A novel compound is disclosed which includes a ligand LA of Formula II, wherein: ring B is independently a 5-membered or 6-membered carbocyclic or heterocyclic ring; X1 to X4 are each independently selected from the group consisting of C, N, and CR; at least two adjacent ones of X1, X2, X3, and X4 are CR and fused into a five or six-membered aromatic ring R3 represents zero, mono, or up to a maximum allowed substitutions to its associated ring; each R, R1, and R3 is independently hydrogen or a General Substituent defined herein; R2 is a General Substituent defined herein; and two substituents can be joined or fused to form a ring; the ligand LA is complexed to a metal M through the two indicated dash lines of each Formula; and the ligand LA can be joined with other ligands to form a tridentate, tetradentate, pentadentate, or hexadentate ligand.

Abstract: A compound having a formula M(LA)x(LB)y(LC)z is provided. In the compound of M(LA)x(LB)y(LC)z, ligand LA is ligand LB is and ligand LC is In addition, M is a metal having an atomic mass greater than 40, x is 1, 2, or 3, and y and z are independently 0, 1, or 2. In the compound, Z5 is carbon or nitrogen; one of Z1 to Z4 is nitrogen and three of Z1 to Z4 are carbon substituted by RB, and rings C and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring. Each RA, RB, RC, and RD is independently selected from a group of substituents, where at least one RB is heteroaryl, which can be further substituted, and any adjacent substitutents are optionally joined or fused into a ring. Formulations and devices, such as OLEDs, that include the first compound are also provided.

Abstract: A compound comprising a first ligand LA having a structure of Formula I, is provided. In Formula I, L is a direct bond a specified linker; each of X1 to X4 is C or N; K is a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), or Si(R?)(R?); at least one RA or RB is R*, comprising a structure of Formula II, each of moiety A, B, and C is a monocyclic ring or a polycyclic fused ring system; n is an integer from 1 to 6; LR is a direct bond or an organic linker; each Z is CR, CRR?, SiRR?, or GeRR?; at least one Z is SiRR? or GeRR?; and LA is coordinated to a metal M selected. Formulations, OLEDs, and consumer products comprising the compound are also provided.

Abstract: A composition including a first compound capable of functioning as a phosphorescent emitter in an OLED is provided. The first compound has at least one aromatic ring and at least one substituent R directly bonded to one of the at least one aromatic rings. Each substituent R has the formula of where (a) G1 is selected from NR1, SiR1R2, GeR1R2, alkyl, cycloalkyl, and combinations thereof; and G2 is a non-aromatic polycyclic group; (b) G1 is a direct bond; and G2 is a non-aromatic spiro polycyclic group; or (c) G1 is selected from direct bond, NR1, SiR1R2, GeR1R2, alkyl, cycloalkyl, and combinations thereof; G2 is a non-aromatic polycyclic group; and R is directly bonded to a phenyl, pyridine, or triazine. R1, R2, and R3 are are a variety of substituents. Formulations and devices, such as an OLEDs, that include the first compound are also described.

Abstract: A compound comprising a first ligand LA having a Formula selected from: is disclosed. In the Formulas rings B and C are 5-membered or 6-membered aromatic or heteroaromatic ring; Z1, Z2, X1, X2, X3, X4, X5, and X6 are each C or N, but X1, X2, X3, or X4 is C when it forms a direct bond to Z2; Y is selected from CRR?, NR?, O, S, and Se; R, R?, RA, RB, RC, and RD are each selected from a variety of substituents; the ligand LA is coordinated to a metal M by the dashed lines, and optionally to other ligands. Organic light emitting devices and consumer products containing the compounds are also disclosed.

Abstract: A compound of Formula Ir(LA)n(LB)m(LC)p is provided where m and n are 1 or 2, p is 0 or 1, and m+n+p=3. Ligand LA has a structure of ligand LB has a structure of and ligand LC is a bidentate ligand. In the compound, ring A? is a ring or is absent; each of R1 and R1? is alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, silyl, germyl, or a combination thereof; moiety C is a monocyclic ring or a fused ring system; each of Z1 and Z2 and X1 to X11 is independently C or N, except that X12 and X13 are C if ring A? is present; each RA, RA?, RB, RC, and RD is hydrogen or one of the General Substituents; and at least one RC or RD comprises an electron withdrawing group. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: An OLED including an anode, a cathode, and an organic layer between the anode and the cathode, where the organic layer includes a compound having the formula [LA]3-nIr[LB]n is disclosed.

Abstract: Provided is a compound having a formula of Ir(LA*)m(LB*)n(LC*)p; wherein each LA, LB, and LC is independently a monoanionic bidentate ligand and different from each other; n and p each is independently 0, 1, or 2; m is 1 or 2; and m+n+p is 3; a free-state of LA has a first triplet energy T1 of EA at 77K; a free-state of LB has a first triplet energy T1 of EB at 77K; a free-state of LC has a first triplet energy T1 of EC at 77K; EA is less than EB and EC whichever EB and EC is present; LA comprises at least one ?-electron deficient electron-withdrawing group; and the compound has an emission spectrum with a FWHM value of no more than 45 nm. Also provided is a compound comprising a first ligand LA having a structure of Formula I, wherein the variables are defined herein.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, each of X1 to X12 is C or N; Y is a linking group; each RA, RB and RC can be hydrogen or a substituent; at least one RA, RB or RC comprises an electron-withdrawing group; and LA forms a 5-membered chelate ring with an Ir atom via the dashed lines. In addition a number of conditions must be met based on whether or not any pair of RA is joined to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: Provided are compounds having a formula of Ir(LA)p(LB)q(LC)r, wherein LA has a structure of Formula IA: LB has a structure of Formula IB: . Also provided are formulations comprising these compounds. Further provided are OLEDs and related consumer products that utilize these compounds.